Publications by authors named "Anette Magnussen"

Claim this Profile
C
Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers.
Andrew Erickson, Sandy Figiel, Timothy Rajakumar, Srinivasa Rao, Wencheng Yin, Anette Magnussen

PLoS One· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
Sandy Figiel, Wencheng Yin, Dimitrios Doultsinos, Andrew Erickson, Ninu Poulose, Anette Magnussen

Mol Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Anette Magnussen, Charlotte Reburn, Alexis Perry, Mark Wood, Alison Curnow

Lasers Med Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular normalisation as the stepping stone into tumour microenvironment transformation.
Anette L Magnussen, Ian G Mills

Br J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
Hanna T Sjoberg, Yiannis Philippou, Anette L Magnussen, Iain D C Tullis, Esther Bridges

Br J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Lizette Anayo, Anette Magnussen, Alexis Perry, Mark Wood, Alison Curnow

Lasers Surg Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Anette L Magnussen, Emma S Rennel, Jing Hua, Heather S Bevan, Nicholas Beazley Long

Invest Ophthalmol Vis Sci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human VEGF165b inhibits experimental choroidal neovascularization.
Jing Hua, Christine Spee, Satoru Kase, Emma S Rennel, Anette L Magnussen

Invest Ophthalmol Vis Sci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6.
M A Hamdollah Zadeh, Catherine A Glass, Anette Magnussen, Jules C Hancox, David O Bates

Microcirculation· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice.
Emma S Rennel, Maryam A Hamdollah-Zadeh, Edward R Wheatley, Anette Magnussen, Yvonne Schüler

Eur J Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.
Patricia Parsons-Wingerter, Ian M Kasman, Scott Norberg, Anette Magnussen, Sara Zanivan

Am J Pathol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.
Anette Magnussen, Ian M Kasman, Scott Norberg, Peter Baluk, Richard Murray

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis